CRIS Current Research Information System

CHIODO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.135
AS - Asia 6.769
EU - Europa 5.917
SA - Sud America 517
AF - Africa 395
Continente sconosciuto - Info sul continente non disponibili 242
OC - Oceania 6
Totale 20.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.050
CN - Cina 2.310
GB - Regno Unito 1.890
SG - Singapore 1.700
VN - Vietnam 1.354
DE - Germania 806
UA - Ucraina 794
SE - Svezia 582
IT - Italia 504
FR - Francia 447
HK - Hong Kong 413
BR - Brasile 367
IN - India 357
RU - Federazione Russa 348
JP - Giappone 213
IE - Irlanda 180
KR - Corea 177
ZA - Sudafrica 152
NL - Olanda 125
SC - Seychelles 78
CI - Costa d'Avorio 72
AR - Argentina 69
EE - Estonia 67
FI - Finlandia 63
TG - Togo 54
CA - Canada 41
BD - Bangladesh 40
PH - Filippine 37
ID - Indonesia 26
BG - Bulgaria 21
EC - Ecuador 21
TH - Thailandia 21
MX - Messico 20
CH - Svizzera 18
IQ - Iraq 18
GR - Grecia 17
PY - Paraguay 17
CO - Colombia 15
JO - Giordania 15
CL - Cile 14
TR - Turchia 13
AT - Austria 12
PK - Pakistan 11
PL - Polonia 11
TW - Taiwan 11
UZ - Uzbekistan 10
SA - Arabia Saudita 9
IR - Iran 8
VE - Venezuela 8
RO - Romania 7
AU - Australia 6
CR - Costa Rica 5
DZ - Algeria 5
LB - Libano 5
NG - Nigeria 5
PE - Perù 5
TN - Tunisia 5
ET - Etiopia 4
JM - Giamaica 4
KE - Kenya 4
PS - Palestinian Territory 4
CZ - Repubblica Ceca 3
ES - Italia 3
HU - Ungheria 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
AO - Angola 2
BE - Belgio 2
BS - Bahamas 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GY - Guiana 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 20.730
Salva come PNG Salva come JPEG
Città #
Southend 1.684
Singapore 1.106
Hefei 651
Fairfield 642
Jacksonville 582
Ashburn 548
Hong Kong 400
Chandler 385
Santa Clara 378
Wilmington 361
San Jose 319
Woodbridge 304
Princeton 303
Seattle 288
Dong Ket 285
Houston 284
Cambridge 247
Ho Chi Minh City 245
Lauterbourg 201
Hanoi 200
Tokyo 195
Nanjing 188
Council Bluffs 186
Dublin 179
Beijing 178
Boardman 170
Seoul 169
Ann Arbor 163
Padova 160
Westminster 150
Berlin 128
Los Angeles 118
Mülheim 89
Saint Petersburg 82
Jinan 81
Buffalo 78
Abidjan 72
Mahé 71
Shenyang 70
Milan 69
Helsinki 57
Lomé 54
New York 53
Hebei 52
Medford 47
The Dalles 47
Nanchang 46
San Diego 45
Verona 44
Tianjin 42
Bengaluru 41
Changsha 41
Hangzhou 38
São Paulo 37
Haiphong 36
Dallas 33
Bologna 32
Guangzhou 32
Zhengzhou 31
Da Nang 30
Shanghai 29
Ningbo 25
San Francisco 23
Chicago 22
Dearborn 22
Frankfurt am Main 22
Jiaxing 22
Norwalk 22
Phoenix 21
Rio de Janeiro 21
Sofia 21
Kunming 18
Lanzhou 18
London 18
Turin 18
Fuzhou 17
Olalla 17
Amman 15
Haikou 15
Atlanta 14
Biên Hòa 14
Bühl 14
Redondo Beach 13
Redwood City 13
Falkenstein 12
Montreal 12
Salvador 12
Taizhou 12
Wuhan 12
Bangkok 11
Hải Dương 11
Nuremberg 11
Orem 11
Xi'an 11
Yubileyny 11
Can Tho 10
Denver 10
Des Moines 10
Düsseldorf 10
Shijiazhuang 10
Totale 13.477
Salva come PNG Salva come JPEG
Nome #
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 270
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 229
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 221
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 217
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 213
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 198
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 195
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 193
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 190
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 186
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 185
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 184
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 181
Prevalence And Mutational Pattern Of Occult Hepatitis B Virus Isolated From Liver Tissue Of HIV Infected Patients 180
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 178
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 178
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 176
Pancreotoxicity of propofol sedation during purulent meningitis. 176
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 175
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 174
Measles outbreak in the city of Bologna, December 2007 to May 2008 172
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 170
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 169
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 168
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 166
Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention. 166
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 165
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 165
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 165
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 165
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 164
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 164
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 164
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 163
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 163
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 162
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 161
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 160
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 160
Legionnaires' disease associated with macular rash: two cases 159
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 159
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 158
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 157
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 157
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 157
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 156
Neurosyphilis in a young adult: very early tertiary syphilis? 156
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 156
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 156
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 154
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 150
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 150
Antiretroviral treatment and gynecomastia: which correlations? 147
Comparison between switching therapy from protease inhibitors to an NNRTI and lipid-lowering therapy with pravastatin or bezafibratef for the management of HAART-related dyslipidemia 147
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 147
Multiple, severe lung infiltrates due to Mycobacterium avium-intracellulare in a patient with decompensated liver cirrhosis: spontaneous resolution after a two-year follow-up 147
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis 147
Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: a rare, but intriguing association. Two case reports and literature review 145
An extremely different dysmetabolic profile between the two available nonucleoside reverse transcriptase inhibitors: efavirenz and nevirapine. 144
Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass 144
Concurrent naso-pharyngeal squamous cell carcinoma and lymphoproliferative disorder during HIV infection. Possible pathogenetic interactions among retroviral infection, Epstein-Barr virus infection, and inhalatory cocaine abuse 143
Hyperacute fulminant fungal peritonitis and ascites in a HIV-infected patient with HCV-related, compensated liver cirrhosis. A supportive role for prolonged nimesulide self-administration? 143
The "Great Imitator". Syphilis as causative agent of isolated, concurrent acute hepatitis and meningitis 143
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds 142
Sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) to antimicrobial agents other than beta-lactams: profile and trend, 1998-2003 141
First-line efavirenz- versus lopinavir-ritonavir-based highly active antiretroviral therapy for naive patients 141
The role of the novel HIV fusion inhibitor enfuvirtide in multiresistant vertical AIDS treated since birth 140
Disorders of glucose metabolism and insulin resistance in HIV-infected patients treated with protease inhibitors: considerations on frequency and clinical management, in a prospective, randomized study 139
Una rara complicanza infettiva in corso di trapianto ortotopico di fegato: gestione della peritonite tubercolare 139
Changing epidemiology of acute hepatitis A and hepatitis B in Italy: further counselling and prophylactic measures are needed for male homo-bisexual subjects? 138
Terapia antiretrovirale con inibitori nucleosidici della trascrittasi inversa ed epatotossicità nei pazienti HIV positivi 138
Acute reactivation of a severe pulmonary tuberculosis during associated interferon pegylate-ribavirin treatment carried out for a known chronic hepatitis C 138
Changing epidemiology of hepatitis A in Italy 137
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 136
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. 136
Bartonellosis: light and shadows in diagnostic and therapeutic issues 135
Gynecomastia in a vertically-infected adolescent treated since birth 133
Dyslipidaemia during HIV disease: a comparison of efavirenz- and nevirapine-based regimens 132
Slowly progressing and indolent pulmonary mucormycosis (zigomycosis) in a patient with an underlying multiple sclerosis, managed without immunosuppressive therapy 132
Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid - meropenem treatment 132
Increased patients' age: a mounting epidemiological, clinical, and therapeutic problem in the HIV disease scenario 131
Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogue. 131
Symptomatic, primary Cytomegalovirus (CMV) infection in otherwise healthy adults. Increased incidence, or increased resort to improved laboratory facilities? 130
Increasing reports of gynecomastia among HIV-infected patients treated with highly active antiretroviral therapy. Epidemiological and clinical correlates, and suggestions for pathogenetic 129
Limited access to hospitalization in an Italian infectious disease ward 129
Secondary syphilis presenting with acute severe hepatic involvement in a patient with undiagnosed HIV disease 129
Severe pneumococcal meningitis heralding a deep hypogammaglobulinaemia related to common variable immunodeficiency, at the age of 27 years. 128
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART 128
AIDS e patologie tumorali multiple come condizioni emergenti in epoca di terapia antiretrovirale altamente attiva (HAART) 128
Nucleoside analogue transcriptase inhibitors and liver toxicity among patients treated for hiv disease 127
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors. 127
Quantitative-qualitative burden of admissions of Extra-Western Europe citizens in a reference Infectious Disease unit in Northern Italy, 1999-2004 125
Syphilis does not seem to involve virological and immunological course of concurrent HIV disease 125
A case-control study of HIV-associated pancreatic abnormalities during HAART era. Focus on emerging risk factors and specific management. 125
How to evaluate rise in serum lactate levels of HIV-infected patients undergoing antiretroviral therapy? Data from a prospective, case-control survey. 124
HIV-associated polymyositis. A rare complication prompted by antiretroviral-related immune reconstitution 124
Severe mediastinal tuberculosis with bronchial and thoracic aortic compression and long-term esophageal fistulization, in a patient with negative history and pulmonary signs and symptoms of tuberculosis 124
Antibiotic therapy for infective endocarditis in childhood 124
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 124
The two non-nucleoside HIV reverse transcriptase inhibitors:significantly different dysmetabolic profile between efavirenz and nevirapine 123
Totale 15.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.485 287 111 205 266 200 146 42 158 67 185 437 381
2022/20231.972 277 343 128 234 101 116 69 82 336 40 187 59
2023/2024367 38 73 35 28 23 67 18 20 8 31 13 13
2024/20252.382 43 519 229 155 578 88 115 25 5 152 12 461
2025/20266.192 299 907 818 705 699 352 397 188 978 404 199 246
2026/2027121 121 0 0 0 0 0 0 0 0 0 0 0
Totale 20.981